Clinical Trial

Cognitive and Fusion Prostatic Biopsy

Study acronym: CTB-FTB
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 5, 2026 (before its estimated May 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to compare two different prostate biopsy techniques used to detect prostate cancer. These techniques are cognitive-targeted biopsy (CTB) and magnetic resonance imaging-ultrasound fusion-targeted transrectal biopsy (FTB). Both methods aim to improve the accuracy of prostate cancer detection by targeting suspicious areas identified on prostate imaging. This study will compare how accurately each technique detects prostate cancer, the pathological findings obtained from each biopsy method, and how operator performance may influence the procedure. The information gained from this study may help improve prostate cancer diagnosis and guide future biopsy practices.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-13; most recent amendment 2026-01-01.
Status change: Not Yet Recruiting → Recruiting 2026-01-01
Trial Details
NCT Number NCT07306741
Lead Sponsor Menoufia University
Conditions Prostate Cancer
Enrollment 80 participants
Start Date 2025-12-28
Primary Completion 2026-05-05 (estimated)
Study Completion 2026-08-05 (estimated)
Updated on ClinicalTrials.gov 2026-01-05